DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID ▼ | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0600139 | Prostate carcinoma | HSD17B4 | 3295 | hydroxysteroid 17-beta dehydrogenase 4 | P51659 |
C0600139 | Prostate carcinoma | HSD17B2 | 3294 | hydroxysteroid 17-beta dehydrogenase 2 | P37059 |
C0600139 | Prostate carcinoma | KLRB1 | 3820 | killer cell lectin like receptor B1 | Q12918 |
C0600139 | Prostate carcinoma | HSD17B1 | 3292 | hydroxysteroid 17-beta dehydrogenase 1 | P14061 |
C0600139 | Prostate carcinoma | CYP4F3 | 4051 | cytochrome P450 family 4 subfamily F member 3 | Q08477 |
C0600139 | Prostate carcinoma | L1CAM | 3897 | L1 cell adhesion molecule | P32004 |
C0600139 | Prostate carcinoma | CEACAM6 | 4680 | CEA cell adhesion molecule 6 | P40199 |
C0600139 | Prostate carcinoma | ACLY | 47 | ATP citrate lyase | P53396 |
C0600139 | Prostate carcinoma | ARSF | 416 | arylsulfatase F | P54793 |
C0600139 | Prostate carcinoma | OLR1 | 4973 | oxidized low density lipoprotein receptor 1 | P78380 |
C0600139 | Prostate carcinoma | ALDH7A1 | 501 | aldehyde dehydrogenase 7 family member A1 | P49419 |
C0600139 | Prostate carcinoma | OPCML | 4978 | opioid binding protein/cell adhesion molecule like | Q14982 |
C0600139 | Prostate carcinoma | HSD17B7 | 51478 | hydroxysteroid 17-beta dehydrogenase 7 | P56937 |
C0600139 | Prostate carcinoma | PIK3CB | 5291 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | P42338 |
C0600139 | Prostate carcinoma | PCYT1A | 5130 | phosphate cytidylyltransferase 1, choline, alpha | P49585 |
C0600139 | Prostate carcinoma | ENPP2 | 5168 | ectonucleotide pyrophosphatase/phosphodiesterase 2 | Q13822 |
C0600139 | Prostate carcinoma | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0600139 | Prostate carcinoma | PIK3CG | 5294 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | P48736 |
C0600139 | Prostate carcinoma | PKD1 | 5310 | polycystin 1, transient receptor potential channel interacting | P98161 |
C0600139 | Prostate carcinoma | PI4KA | 5297 | phosphatidylinositol 4-kinase alpha | P42356 |
C0600139 | Prostate carcinoma | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0600139 | Prostate carcinoma | PLAUR | 5329 | plasminogen activator, urokinase receptor | Q03405 |
C0600139 | Prostate carcinoma | PLA2G1B | 5319 | phospholipase A2 group IB | P04054 |
C0600139 | Prostate carcinoma | PLD1 | 5337 | phospholipase D1 | Q13393 |
C0600139 | Prostate carcinoma | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024